首页> 外国专利> Combination, use of mirtapazine and gepirone, method for the treatment of depression or a related disorder in an individual of a vertebrate species, and, a patient kit that contains means for the administration of dosed unit doses

Combination, use of mirtapazine and gepirone, method for the treatment of depression or a related disorder in an individual of a vertebrate species, and, a patient kit that contains means for the administration of dosed unit doses

机译:米拉帕嗪和吉哌隆的组合,使用,治疗脊椎动物个体中的抑郁症或相关疾病的方法以及包含用于给予单位剂量剂量的装置的患者药盒

摘要

"COMBINATION, USE OF MIRTAPAZINE AND GEPIRONE, METHOD FOR THE TREATMENT OF DEPRESSION OR RELATED DISORDER IN AN INDIVIDUAL OF A VERTEBRATED SPECIES AND PATIENT KIT CONTAINING MEDIA FOR THE ADMINISTRATION OF THE UNITES OF THE UNITED STATES". The invention relates to a combination, which comprises an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable vehicles, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favorable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides a new method of treating depression and related disorders.
机译:“联合使用米拉他嗪和吉普利酮,用于治疗无脊椎动物和含有患者成套工具的个体的抑郁症或相关疾病的方法,以管理美国各州。”本发明涉及一种组合物,其包含一定量的米氮平或其药学上可接受的盐或溶剂化物,以及一定量的吉哌隆或其药学上可接受的盐或溶剂化物,任选地与一种或多种药学上可接受的媒介物结合,由此吉哌隆的量和米氮平的量应使得组合物的效果比每种药物的量分别增加的效果更有利。该组合可以用于治疗抑郁症和相关疾病,由此本发明还提供了治疗抑郁症和相关疾病的新方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号